Not a U.S. government website. NDD is an independent vulnerability database by Volerion and is not affiliated with or endorsed by NIST or NVD.
VOLERION
Volerion Security Research

NOT DEFERRED DATABASE

VULNERABILITIES

CVE-2015-3965 Details

Description

Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.

Metrics

CVSS 3.x Severity and Vector Strings:

References to Advisories, Solutions, and Tools

By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.

URLSource(s)Tag(s)
https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01 CVEThird Party AdvisoryUS Government Resource
https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01 [email protected]Third Party AdvisoryUS Government Resource

Weakness Enumeration

CWE-IDCWE NameSource
CWE-264Permissions, Privileges, and Access Controls[email protected]

Affected Products

ProductVersions
pfizer symbiq infusion system firmware
<= 3.13

CPE

  • cpe:2.3:o:pfizer:symbiq_infusion_system_firmware:*:*:*:*:*:*:*:*

Remediation

  • No remediation found in references.
pfizer symbiq infusion system
All versions

CPE

  • cpe:2.3:h:pfizer:symbiq_infusion_system:-:*:*:*:*:*:*:*

Remediation

  • No remediation found in references.

Change History

4 change records found show changes


QUICK INFO

CVE Dictionary Entry:
CVE-2015-3965
NVD Published Date:
Mar 23, 2019
NVD Last Modified:
Jun 17, 2026
Source:
[email protected]
CVE-2015-3965 Details - Not Deferred